LPAR5 and lung carcinoma: There is evidence that ATX is highly expressed in poorer differentiated lung carcinomas, particularly in tumor-adjacent B lymphocytes [92] and that LPA5 may play a key role in the progression of these carcinomas [68], while LPA3 could have a protective role [66].